XRCC6P5 and cancer: The underlying hypothesis that prompted this study was that decreased level of DNA repair proteins will sensitize cells to PARPis, and since vorinostat has been demonstrated to specifically reduce the level of DNA repair proteins in cancer but not in normal cells [8] we chose to evaluate its effect on the sensitivity of cancer cells to ABT-888.